What Oura's $625M Counsel Health deal means for primary care

Oura is buying an AI primary care startup for $625 million in cash. Here is what the deal says about AI triage, physician oversight and clinics.

A family physician writes in a printed patient chart at a desk by a rainy window in a small clinic office.

Oura, the company best known for its smart ring, has agreed to buy Counsel Health, a startup that pairs a medical AI chatbot with on-call physicians. The price is $625 million in cash. For clinicians, the deal is less about wearables and more about a question that is coming to every practice: who answers the patient first, and who is accountable when they do?

What happened

On November 10, Oura and Counsel announced a definitive agreement for Oura to acquire Counsel for $625 million in cash, subject to purchase price adjustments. Counsel's announcement says the deal is expected to close before the end of the calendar year, subject to customary closing conditions. TechCrunch, which also reported the deal, gave a later timeline, so the exact close date is worth watching.

Oura says it has over six million members. Alongside the deal, it shared preliminary, unaudited results: revenue of $533 million for the quarter ended September 30, 2026, up 153 per cent year over year, and expected fiscal 2026 revenue of about $1.75 billion. TechCrunch reports that Counsel raised a $25 million Series A a year ago, led by Andreessen Horowitz and GV, and that Counsel was integrated into the Oura app in June.

What Counsel actually does

Counsel describes itself as an "AI-native primary care company" built by physicians and AI researchers. Members chat with Counsel's AI, which draws on connected medical records, past conversations, evidence-based guidelines and, inside Oura, continuous biometric data from the ring. When needed, a board-certified physician can join the same conversation to provide a diagnosis, prescriptions or referrals.

Under the hood, Counsel says it uses a "clinical AI harness" that calls on specialized agents for history taking, guideline retrieval, records review and emergency detection. Each agent is evaluated for performance, safety and quality, and refined with feedback from Counsel's physicians. Doctors work from a tool Counsel calls the Clinician Cockpit, which summarizes the record and longitudinal trends.

Counsel sells mainly through enterprise partners: health plans, health systems, employers and consumer health companies. It says it will keep serving those partners after the deal.

Why the physician in the loop matters

Both companies lean hard on the idea of a supervised model. Counsel founder and CEO Muthu Alagappan said the company has "built medical AI around trust, safety and responsibility, keeping physicians in the loop for clinical decisions." Oura CEO Tom Hale framed it this way: "Oura helps members understand their physiology and, with Counsel, they can take action on their health."

That framing is the real story. Investors are now paying hundreds of millions of dollars for a specific design: AI handles intake and routine questions, and a licensed physician stays responsible for diagnosis and treatment. It is a bet that patients want speed, but that regulators, payers and patients themselves still want a clinician accountable for the decision.

The data question

The deal also joins two kinds of health data that sit under different rules. Oura's own materials state that the Oura Ring is not a medical device. Counsel says its service is HIPAA compliant and SOC 2 secure. When ring data flows into a clinical record, how consent, retention and access are handled will matter a great deal. HIT Consultant noted that whether consumers embrace the model is still an open question at a time of high sensitivity about health data privacy and AI errors.

What we do not know yet

Clinical outcomes. Counsel reports high satisfaction from its own surveys, but none of the announcements include independent data on diagnostic accuracy, safety events or downstream costs.
Physician capacity. No source gives a count of Counsel physicians, so it is hard to judge how escalation will hold up at the scale of millions of members.
Canada. None of the announcements mention Canadian availability. Any similar service here would have to meet provincial licensing rules and laws such as PHIPA.

What this means for clinics

Large consumer brands are moving into the front door of primary care. Patients who get a fast AI answer from an app will expect something similar from their own clinic. Some practical steps:

Expect wearable data at the visit. Decide how your team will handle patients who arrive with months of sleep, heart rate and temperature trends, and what you will and will not review.
Close the gap before the visit. The appeal of these services is that someone listens right away. Clinics can offer the same by collecting a structured history before the appointment.
Keep the clinician accountable. Whatever tools you adopt, make sure a clinician reviews AI output before it shapes care, and that patients know who is responsible.
Ask hard privacy questions. Know where any vendor stores patient data and whether it meets HIPAA in the US or PHIPA and other provincial laws in Canada.

This is the model Athel follows inside the clinic rather than around it. Athel's AI co-clinician interviews patients before the visit by voice, web chat or video, and the physician reviews every structured history, with Canadian and US data residency.

The Oura and Counsel deal shows where the money is going. The clinics that do well will be the ones that give patients speed without giving up clinical judgment.